The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
Shaping the Nrf2-ARE-related pathways in Alzheimer’s and Parkinson’s diseases
Abstract
A failure in redox homeostasis is a common hallmark of Alzheimer's Disease (AD) and Parkinson's Disease (PD), two age-dependent neurodegenerative disorders (NDD), causing increased oxidative stress, oxidized/damaged biomolecules, altered neuronal function and consequent cell death. Activation of nuclear factor erythroid 2-related factor 2 (Nrf2), a redox-regulated transcription factor, results in upregulation of cytoprotective and antioxidant enzymes/proteins, protecting against oxidative stress. Nrf2 regulation is achieved by various proteins and pathways, at both cytoplasmatic and nuclear level; however, the elaborate network of mechanisms involved in Nrf2 regulation may restrain Nrf2 pathway normal activity. Indeed, altered Nrf2 activity is involved in aging and NDD, such as AD and PD. Therefore, understanding the diversity of Nrf2 control mechanisms and regulatory proteins is of high interest, since more effective NDD therapeutics can be identified. In this review, we first introduce Keap1-Nrf2-ARE structure, function and regulation, with a special focus on the several pathways involved in Nrf2 positive and negative modulation, namely p62, PKC, PI3K/Akt/GSK-3β, NF-kB and p38 MAPK. We then briefly describe the evidences for oxidative stress and Nrf2 pathway deregulation in different stages of NDDs. Finally, we discuss the potential of Nrf2-related pathways as potential therapeutic targets to possibly prevent or slowdown NDD progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–271 of 271
Srivastava, S., Blower, P. J., Aubdool, A. A., Hider, R. C., Mann, G. E., & Siow, R. C. M. (2016) · Scientific Reports · doi:10.1038/s41598-016-0012-5 · Cited by 117
Toki, T., Itoh, J., Kitazawa, J., Arai, K., Hatakeyama, K., Akasaka, J.-I., Igarashi, K., Nomura, N., Yokoyama, M., Yamamoto, M. P., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201024 · Cited by 116
Lee, C., Park, G. H., Lee, S., & Jang, J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/313510 · Cited by 105
Hong, Y., & An, Z. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0662-z · Cited by 103
Meng, X., Wang, M., Sun, G., Ye, J., Zhou, Y., Dong, X., Wang, T., Lu, S., & Sun, X. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.03.026 · Cited by 100
Nrf2 Possesses a Redox-insensitive Nuclear Export Signal Overlapping with the Leucine Zipper Motif
Li, W., Jain, M. R., Chen, C., Yue, X., Hebbar, V., Zhou, R., & Kong, A.-N. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410601200 · Cited by 100
Reactive Oxygen and Nitrogen Species in Alzheimers Disease
Aslan, M., & Özben, T. (2004) · Current Alzheimer Research · doi:10.2174/1567205043332162 · Cited by 97
Anderson, G., & Maes, M. H. J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8554-z · Cited by 97
Hernández-Baltazar, D., Mendoza‐Garrido, M. E., & Martínez‐Fong, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070951 · Cited by 97
Prospective Type 1 and Type 2 Disulfides of Keap1 Protein
Holland, R., Hawkins, A., Eggler, A. L., Mesecar, A. D., Fabris, D., & Fishbein, J. C. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800226m · Cited by 97
de Oliveira, M. R., Ferreira, G. C., & Schuck, P. F. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.12.005 · Cited by 97
Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease
Du, Y., Wooten, M. C., & Wooten, M. W. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.015 · Cited by 96
Alural, B., Özerdem, A., Allmer, J., Genç, K., & Genç, Ş. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00209 · Cited by 95
Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice
Zhou, Y., Xie, N., Li, L., Zou, Y. S., Zhang, X., & Dong, M. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571300148x · Cited by 94
Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency
Gatt, A. P., Duncan, O. F., Attems, J., Francis, P. T., Ballard, C. G., & Bateman, J. E. (2016) · Movement Disorders · doi:10.1002/mds.26513 · Cited by 94
Dissecting the role of redox signaling in neuronal development
Bórquez, D. A., Urrutia, P. J., Wilson, C., van Zundert, B., Núñez, M. T., & González-Billault, C. E. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13581 · Cited by 89
Wang, Y., Santa–Cruz, K., DeCarli, C., & Johnson, J. A. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00114-7 · Cited by 87
Karunakaran, S., & Ravindranath, V. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06112.x · Cited by 87
Du, L., Xie, J., Cheng, X., Li, X.-H., Kong, F., Jiang, X., Ma, Z., Wang, J., Chen, C., & Zhou, X. (2013) · AGE · doi:10.1007/s11357-013-9592-1 · Cited by 86
Glycogen synthase kinase-3beta is associated with Parkinson's disease
Nagao, M., & Hayashi, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.104 · Cited by 84
Aguiar, A. S., Duzzioni, M., Remor, A. P., Tristão, F. S. M., MATHEUS, F. C., Raisman‐Vozari, R., Latini, A., & Prediger, R. D. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1709-8 · Cited by 83
The expression of PARP, NF-κB and parvalbumin is increased in Parkinson disease
Soós, J., Engelhardt, J. I., Siklós, L., Havas, L., & Majtényi, K. (2004) · Neuroreport · doi:10.1097/01.wnr.0000136175.51954.ce · Cited by 81
Panet, H., Barzilai, A., Daily, D., Melamed, E., & Offen, D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00213.x · Cited by 81
Tanji, K., Maruyama, A., Odagiri, S., Mori, F., Itoh, K., Kakita, A., Takahashi, H., & Wakabayashi, K. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827b5713 · Cited by 80
Kwon, S., Ma, S., Hwang, J.-Y., Lee, S., & Jang, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.030 · Cited by 80
Hasegawa, T., Treis, A., Patenge, N., Fiesel, F. C., Springer, W., & Kahle, P. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05277.x · Cited by 79
Brain aluminum in Alzheimer's disease using an improved GFAAS method.
Xu, N., Majidi, V., Markesbery, W. R., & Ehmann, W. D. (1992) · PubMed · Cited by 78
Fragoulis, A., Siegl, S., Fendt, M., Jansen, S., Soppa, U., Brandenburg, L., Pufe, T., Weis, J., & Wruck, C. J. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.024 · Cited by 77
An Autoregulatory Loop between Nrf2 and Cul3-Rbx1 Controls Their Cellular Abundance
Kaspar, J. W., & Jaiswal, A. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121863 · Cited by 76
Li, C., Tang, B.-Q., Feng, Y., Tang, F., Hoi, M. P. M., Su, Z., & Lee, S. M. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b02607 · Cited by 76
Amyloid beta peptide directly inhibits PKC activation
Lee, W., Boo, J. H., Jung, M. W., Park, S. D., Kim, Y. H., Kim, S. U., & Mook‐Jung, I. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.10.020 · Cited by 73
Zhang, X., Yuan, Y., Shao, Q.-H., Wang, Z., Zhu, C., Shi, J., Ma, K., Xu, Y., & Chen, N. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.02.022 · Cited by 68
Impaired Complex-I Mitochondrial Biogenesis in Parkinson Disease Frontal Cortex
Thomas, R. R., Keeney, P. M., & Bennett, J. P. (2012) · Journal of Parkinson s Disease · doi:10.3233/jpd-2012-11074 · Cited by 65
Nrf2 Signaling Contributes to the Neuroprotective Effects of Urate against 6-OHDA Toxicity
Zhang, N., Shu, H., Huang, T., Zhang, Q., Li, D., Zhang, G., Peng, X., Liu, C., Luo, W., & Hu, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100286 · Cited by 65
Mercado-Gómez, O. F., Hernández‐Fonseca, K., Villavicencio‐Queijeiro, A., Massieu, L., Chimal‐Monroy, J., & Arias, C. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9714-9 · Cited by 63
Chang, W.-H., Chen, M. C., & Cheng, I. H.-J. (2015) · Scientific Reports · doi:10.1038/srep15067 · Cited by 62
Talman, V., Pascale, A., Jäntti, M. H., Amadio, M., & Tuominen, R. K. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12581 · Cited by 61
Zhao, Y., Zhang, Q., Xi, J., Li, Y., Ma, C., & Xiao, B. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.03.022 · Cited by 58
Xie, G., Tian, W., Wei, T., & Liu, F. (2014) · Free Radical Research · doi:10.3109/10715762.2014.987274 · Cited by 57
Xu, W., Zheng, D., Liu, Y., Li, J., Yang, L., & Shang, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485947 · Cited by 57
Neophobia, NQO1 and SIRT1 as premorbid and prodromal indicators of AD in 3xTg-AD mice
Torres–Lista, V., Parrado‐Fernández, C., Alvarez-Montón, I., Frontiñán-Rubio, J., Durán‐Prado, M., Peinado, J. R., Johansson, B. A., Alcain, F. J., & Giménez‐Llort, L. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.055 · Cited by 56
Jakel, R. J., Kern, J. T., Johnson, D. A., & Johnson, J. A. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi241 · Cited by 55
Isagawa, T., Mukai, H., Oishi, K., Taniguchi, T., Hasegawa, H., Kawamata, T., Tanaka, C., & Ono, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2926 · Cited by 55
Tyszkiewicz, J. P., & Yan, Z. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00939.2004 · Cited by 55
Egea, J., Buendía, I., Parada, E., Navarro, E., Rada, P., Cuadrado, A., López, M. G., García, A. G., & Leon, R. M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13025 · Cited by 54
Weinreb, O., Amit, T., Bar‐Am, O., Sagi, Y., Mandel, S. A., & Youdim, M. B. H. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_69 · Cited by 52
Tian, Y., Wang, W., Xu, L., Li, H., Wei, Y., Wu, Q., & Jia, J. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24357 · Cited by 50
p 62 Deficiency Enhances α‐Synuclein Pathology in Mice
Tanji, K., Odagiri, S., Miki, Y., Maruyama, A., Nikaido, Y., Mimura, J., Mori, F., Warabi, E., Yanagawa, T., Ueno, S., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12214 · Cited by 49
Perfeito, R., Ribeiro, M., & Rego, A. C. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1788-6 · Cited by 48
Self-citationLin, W., Ding, M., Xue, J., & Leng, W. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.09.016 · Cited by 46
Kim, C., Ojo-Amaize, E., Spencer, B., Rockenstein, E., Mante, M., Desplats, P., Wrasidlo, W., Adame, A., Nchekwube, E., Oyemade, O., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0455-9 · Cited by 45
Blum, D. L., Torch, S., Nissou, M.-F., & Verna, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00680-3 · Cited by 44
Onyango, I. G., Tuttle, J. B., & Bennett, J. P. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.10.006 · Cited by 43
Gu, C., Zhang, Y., Hu, Q., Wu, J., Ren, H., Liu, C., & Wang, G. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.250 · Cited by 42
Antiapoptotic role of NF‐κB in the auto‐oxidized dopamine‐induced apoptosis of PC12 cells
Lee, H., Kim, S., Kim, K., Um, J., Lee, H. W., Chung, B., & Kang, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00076.x · Cited by 41
Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons
Zawada, W. M., Meintzer, M. K., Rao, P., Marotti, J. D., Wang, X., Esplen, J. E., Clarkson, E. D., Freed, C. R., & Heidenreich, K. A. (2001) · Brain Research · doi:10.1016/s0006-8993(00)02965-6 · Cited by 40
Murphy, K. E., Llewellyn, K., Wakser, S., Pontasch, J., Samanich, N., Flemer, M., Hensley, K., Kim, D., & Park, J. C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001245 · Cited by 39
Role for PKC-ε in neuronal death induced by oxidative stress
Jung, Y.-S., Ryu, B., Lee, B., Mook-Jung, I., Kim, S., Lee, S. H., Baik, E., & Moon, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.217 · Cited by 38
Zou, Y., Wang, R., Guo, H., & Dong, M. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv111 · Cited by 36
Increased 8-OHdG levels in the urine, serum, and substantia nigra of hemiparkinsonian rats
Yasuhara, T., Hara, K., Sethi, K. D., Morgan, J. C., & Borlongan, C. V. (2007) · Brain Research · doi:10.1016/j.brainres.2006.11.072 · Cited by 34
Gureev, A. P., Syromyatnikov, M., Gorbacheva, T., Starkov, A. A., & Popov, V. N. (2016) · Neuroscience Research · doi:10.1016/j.neures.2016.07.006 · Cited by 30
Sulfuretin Attenuates MPP+-Induced Neurotoxicity through Akt/GSK3β and ERK Signaling Pathways
Pariyar, R., Lamichhane, R., Jung, H., Kim, S. H., & Seo, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122753 · Cited by 27
The Role of CNI-1493 in the Function of Primary Microglia with Respect to Amyloid-β
Bach, J., Mengel, D., Wahle, T., Kautz, A., Balzer‐Geldsetzer, M., Al‐Abed, Y., Dodel, R. C., & Bacher, M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110179 · Cited by 25
Bacher, M., Dodel, R. C., Aljabari, B., Keyvani, K., Marambaud, P., Kayed, R., Glabe, C. G., Goertz, N., Hoppmann, A., Sachser, N., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20060467 · Cited by 24
c-Src regulates Nrf2 activity through PKCδ after oxidant stimulus
Fão, L., Mota, S. I., & Rego, A. C. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.01.011 · Cited by 24
Self-citationEffect of p62 on tau hyperphosphorylation in a rat model of Alzheimer's disease.
Zheng, X., Wang, W., Liu, R., Huang, H., Zhang, R., & Sun, L. (2012) · PubMed Central · doi:10.3969/j.issn.1673-5374.2012.17.004 · Cited by 22
The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases
Obuobi, S. A. O., Karatayev, S., Chai, C. L. L., Ee, P. L. R., & Mátyus, P. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1205047 · Cited by 21
Huang, L., Deng, M., He, Y., & Fang, Y. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12344 · Cited by 20
Mitra, S., Ghosh, N., Sinha, P., Chakrabarti, N., & Bhattacharyya, A. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.046 · Cited by 19
Potential of Asian Natural Products for Health in Aging
Cheung, B., Kwan, M., Chan, R., Sea, M. M.-M., & Woo, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801816-3.00047-9 · Cited by 13
hDKIR, a human homologue of the Drosophila kelch protein, involved in a ring-like structure
Mai, A., Jung, S., & Yonehara, S. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.06.023 · Cited by 8
Cited by
Hypoxia and brain aging: Neurodegeneration or neuroprotection?
Burtscher, J., Mallet, R. T., Burtscher, M., & Millet, G. P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101343 · Cited by 324
Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance
Nehra, G., Bauer, B., & Hartz, A. M. S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108119 · Cited by 127
Wu, X., Yang, Z., Zou, J., Gao, H., Shao, Z., Li, C., & Lei, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02179-x · Cited by 88
“217,261 267 However, unlike p38 α -MAPK, p38 γ -MAPK is speci fi cally localized to the post-synaptic density in neurons and mediates the phosphorylation of postsynaptic tau protein at Thr205.”
Han, X., Ding, C., Zhang, G., Pan, R., Liu, Y., Huang, N., Hou, N., Han, F., Xu, W., & Sun, X. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.032 · Cited by 63
Pan, S., Wei, H., Yuan, S., Kong, Y., Yang, H., Zhang, Y., Cui, X., Chen, W., Liu, J., & Zhang, Y. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1022879 · Cited by 51
Metadata
- Authors
- Fão, L., Mota, S. I., & Rego, A. C.
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 54
- Pages
- 100942
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W2968164813
- Cited by
- 270
- References
- 271
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.